CS Diagnostics Corp. (CSDX)

CS Diagnostics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2009	FY 2008	FY 2007
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Net Income	0.02	0	-0.02	-0.27	-0.4	-1.17
Depreciation & Amortization	-	-	-	0	0	0.01
Stock-Based Compensation	-	-	-	-	-	0.11
Other Operating Activities	-	-	-	-	0	-0
Change in Accounts Receivable	0.03	0.01	-	-	-	-
Change in Accounts Payable	0.01	0	0.03	0.3	0.01	0.39
Change in Other Net Operating Assets	-	-	-	-0.03	-0.35	0.65
Operating Cash Flow	0.06	0.01	0.01	-0	-0.73	-0.01
Operating Cash Flow Growth	-	18.77%	-	-	-	-
Capital Expenditures	-	-	-	-	-0.01	-0
Sale (Purchase) of Intangibles	-998.89	-499.44	-499.44	-	-	-
Investing Cash Flow	-998.89	-499.44	-499.44	-	-0.01	-0
Long-Term Debt Issued	-	-	-	-	-	0.01
Total Debt Issued	-	-	-	-	-	0.01
Long-Term Debt Repaid	-	-	-	-	-1.03	-
Total Debt Repaid	-	-	-	-	-1.03	-
Net Debt Issued (Repaid)	-	-	-	-	-1.03	0.01
Issuance of Common Stock	998.89	499.44	499.42	-	1.77	-
Financing Cash Flow	998.89	499.44	499.42	-	0.74	0.01
Miscellaneous Cash Flow Adjustments	-0	-0	-	-	-0	-
Net Cash Flow	0.06	0.01	-0.01	-0	-0	-0
Free Cash Flow	0.06	0.01	0.01	-0	-0.74	-0.02
Free Cash Flow Growth	-	18.77%	-	-	-	-
Free Cash Flow Margin	50.44%	9.95%	7.37%	-	-	-2021.80%
Free Cash Flow Per Share	-	-	-	-0.00	-7.69	-
Levered Free Cash Flow	-	-499.46	-	0.13	-0.2	0.12
Unlevered Free Cash Flow	-	-499.46	-	0.13	-0.2	0.12
Change in Working Capital	0.04	0.01	0.03	0.27	-0.33	1.04

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.